Bristol-Myers Squibb BMY Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's total current assets?
- Bristol-Myers Squibb (BMY) reported total current assets of $28.58B in Q2 2026.
- How has Bristol-Myers Squibb's total current assets changed year-over-year?
- Bristol-Myers Squibb's total current assets decreased by 14.0% year-over-year, from $33.22B to $28.58B.
- What is the long-term trend for Bristol-Myers Squibb's total current assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current assets has grown at a -0.5% compound annual growth rate (CAGR), from $30.19B to $29.39B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.